Walleye Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 2336 |
|
|
2025
Q1 | – | Sell |
-134,006
| Closed | -$12.1M | – | 2433 |
|
|
2024
Q4 | $12.1M | Sell |
134,006
-26,619
| -17% | -$2.4M | 0.03% | 222 |
|
|
2024
Q3 | $15.9M | Sell |
160,625
-7,701
| -5% | -$761K | 0.03% | 162 |
|
|
2024
Q2 | $15.6M | Buy |
168,326
+102,801
| +157% | +$9.53M | 0.03% | 154 |
|
|
2024
Q1 | $6.22M | Buy |
+65,525
| New | +$6.22M | 0.01% | 372 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3080 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3059 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2924 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2666 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2811 |
|
|
2021
Q1 | – | Sell |
-4,826
| Closed | -$679 | – | 1363 |
|
|
2020
Q4 | $679 | Buy |
+4,826
| New | +$679 | 0.05% | 369 |
|